Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complementary or alternative medicine: the need for plausibility.

Literature DB >> 12538547

Complementary or alternative medicine: the need for plausibility.

L John Hoffer¹.

Abstract

Mesh：

Year: 2003 PMID： 12538547 PMCID： PMC140428

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

22 in total

1. Randomized controlled trials: the control group dilemma revisited.

Authors: A Hart
Journal: Complement Ther Med Date: 2001-03 Impact factor: 2.446

2. Designing and funding clinical trials of novel therapies.

Authors: K Antman; S Lagakos; J Drazen
Journal: N Engl J Med Date: 2001-03-08 Impact factor: 91.245

3. Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.

Authors: L J Hoffer
Journal: CMAJ Date: 2001-02-06 Impact factor: 8.262

4. Complementary and alternative medicine: the role of the cancer center.

Authors: K Antman; M C Benson; J Chabot; D Cobrinik; V R Grann; J S Jacobson; A K Joe; A E Katz; K Kelly; A I Neugut; D Russo; A Tiersten; I B Weinstein
Journal: J Clin Oncol Date: 2001-09-15 Impact factor: 44.544

Review 5. Comparison of evidence of treatment effects in randomized and nonrandomized studies.

Authors: J P Ioannidis; A B Haidich; M Pappa; N Pantazis; S I Kokori; M G Tektonidou; D G Contopoulos-Ioannidis; J Lau
Journal: JAMA Date: 2001-08-15 Impact factor: 56.272

Review 6. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.

Authors: A Hróbjartsson; P C Gøtzsche
Journal: N Engl J Med Date: 2001-05-24 Impact factor: 91.245

7. A recruitment strategy for cluster randomized trials in secondary care settings.

Authors: A E Walker; M K Campbell; J M Grimshaw
Journal: J Eval Clin Pract Date: 2000-05 Impact factor: 2.431

8. Alternative therapies getting notice through Best Case Series Program.

Authors: C Vanchieri
Journal: J Natl Cancer Inst Date: 2000-10-04 Impact factor: 13.506

9. The case for uncontrolled clinical trials: a starting point for the evidence base for CAM.

Authors: A White; E Ernst
Journal: Complement Ther Med Date: 2001-06 Impact factor: 2.446

10. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors: F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal: N Engl J Med Date: 2001-01-04 Impact factor: 91.245

5 in total

Complementary or alternative medicine: the need for plausibility.

1. Randomized controlled trials: the control group dilemma revisited.

2. Designing and funding clinical trials of novel therapies.

3. Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.

4. Complementary and alternative medicine: the role of the cancer center.

Review 5. Comparison of evidence of treatment effects in randomized and nonrandomized studies.

Review 6. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.

7. A recruitment strategy for cluster randomized trials in secondary care settings.

8. Alternative therapies getting notice through Best Case Series Program.

9. The case for uncontrolled clinical trials: a starting point for the evidence base for CAM.

10. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

1. Classification of complementary and alternative medical practices: Family physicians' ratings of effectiveness.

2. Investigating CAM.

3. [Not Available].

4. Children and natural health products: What a clinician should know.

5. Intravenously administered vitamin C as cancer therapy: three cases.